Membrane-bound Heat Shock Protein HSP70 as a Target for Theranostics of Tumors

 
PIIS102872210002681-4-1
DOI10.31857/S102872210002681-4
Publication type Article
Status Published
Authors
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Journal nameRossiiskii immunologicheskii zhurnal
EditionVolume 12 Issue 4
Pages802-804
Abstract

  

Keywords
Received29.01.2019
Publication date31.01.2019
Cite   Download pdf To download PDF you should sign in
Размещенный ниже текст является ознакомительной версией и может не соответствовать печатной

views: 1181

Readers community rating: votes 0

1. Shevtsov M., Multhoff G. Heat shock protein-peptide and HSP-based immunotherapies for the treatment of cancer. Front Immunol. 2016, 7, 171.

2. Multhoff G. Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods. 2007, 43, 229–237.

3. Shevtsov M. A., Multhoff G. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor. Current Drug Metabolism. 2016, 17(8), 737–744.

4. Shevtsov M. A., Nikolaev B. P., Ryzhov V. A., Yakovleva L. Y., Marchenko Y. Y., Parr M. A., Rolich V. I., Mikhrina A. L., Dobrodumov A. V., Pitkin E., Multhoff G. Ionizing radiation improves glioma-specifi c targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 antibodies (SPION-cmHsp70.1). Nanoscale. 2015, 7(48), 20652–20664.

Система Orphus

Loading...
Up